02/19/2021
4:01 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2021
10:28 AM | Moleculin Biotech (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/08/2021
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2021
3:07 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2021
8:45 PM | Moleculin Biotech (Filer)
| Form S-3MEF
| |
02/02/2021
8:41 PM | Moleculin Biotech (Filer)
| Form 8-K/A
| |
02/02/2021
3:29 PM | Moleculin Biotech (Filer)
| Form 424B5
| |
02/02/2021
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2021
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2021
8:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/20/2021
10:14 AM | Empery Asset Management, LP (Filed by)
Moleculin Biotech (Subject)
| Form SC 13G/A
| |
01/11/2021
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
1:02 PM | Moleculin Biotech (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
12/29/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2020
3:15 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2020
3:00 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2020
5:01 AM | Lincoln Park Capital Fund, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SC 13G
| |
11/12/2020
3:31 PM | Moleculin Biotech (Filer)
| Form 424B5
| |
10/29/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2020
3:35 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2020
4:26 PM | Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
4:25 PM | Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2020
4:02 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2020
3:30 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2020
3:04 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2020
3:18 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2020
3:12 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2020
3:04 PM | Moleculin Biotech (Issuer)
Priebe Waldemar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
3:31 PM | Moleculin Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2020
6:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2020
6:29 AM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/21/2020
7:41 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2020
4:19 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2020
4:16 PM | Moleculin Biotech (Filer)
| Form 424B5
| |
07/15/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2020
5:03 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2020
4:24 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2020
4:14 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2020
4:13 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2020
6:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2020
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2020
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2020
3:34 PM | CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
3:32 PM | Climaco John M (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
3:30 PM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
3:20 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2020
6:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2020
4:20 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2020
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2020
6:31 AM | Moleculin Biotech (Filer)
| Form DEFA14A
| |
04/23/2020
3:06 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2020
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT
| |
04/08/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2020
3:30 PM | Moleculin Biotech (Filer)
| Form DEF 14A
| |
04/02/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2020
3:34 PM | Moleculin Biotech (Filer)
| Form PRE 14A
| |
03/19/2020
3:16 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2020
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2020
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2020
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2020
6:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2020
1:16 PM | Empery Asset Management, LP (Filed by)
Moleculin Biotech (Subject)
| Form SC 13G
| |
02/10/2020
2:17 PM | CVI Investments, Inc. (Filed by)
Moleculin Biotech (Subject)
| Form SC 13G/A
| |
02/07/2020
12:36 PM | Moleculin Biotech (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
02/06/2020
4:08 PM | Moleculin Biotech (Filer)
| Form 424B5
| |
02/05/2020
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2020
6:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2020
4:17 PM | Moleculin Biotech (Filer)
| Form S-3/A
| |
01/17/2020
3:37 PM | Moleculin Biotech (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/13/2020
6:01 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2019
3:06 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2019
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
6:33 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
3:46 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
5:33 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
5:31 AM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2019
3:01 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2019
6:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
6:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2019
4:18 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2019
4:16 PM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2019
6:34 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
6:48 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2019
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2019
6:02 AM | Moleculin Biotech (Filer)
| Form 424B5
| |
07/18/2019
3:02 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
